Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus versus placebo for neurocognitive problems in tuberous sclerosis
ISRCTN09739757Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Dec 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in tuberous sclerosis complex (TSC) comparing Everolimus with Placebo (2 arms). Primary endpoints: List Learning test, Complex Figure test and 3 more. Started Dec 2011; status: completed.
02
Drugs
everolimus
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on ISRCTN09739757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN09739757.